First published · Last updated
Evaluating the Anticancer and Anti‐Angiogenic Efficacy of Bergaptol in 2D and 3D Tumor Microtissue Models
A Wiley-published journal article reports laboratory evaluation of bergaptol for anticancer and anti-angiogenic effects using two-dimensional and three-dimensional tumor microtissue models. Publication date is 2026-09-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 4/10
- Geographic reach
- 1/10
- Global importance
- 2/10
- Impact magnitude
- 2/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
Results are relevant to cancer research and potential therapeutic development.

